The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Glucocorticoid-Induced Bone Disease
Abstract
This article reviews the risks of osteoporosis and osteonecrosis associated with glucocorticoid use, which are present even in the absence of low bone mineral density, and discusses strategies to reduce the risk of fractures and the data to support the strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
Cummings, S. R., Martin, J. S., McClung, M. R., Siris, E. S., Eastell, R., Reid, I. R., Delmas, P., Zoog, H. B., Austin, M., Wang, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809493 · Cited by 3,489
Liberman, U. A., Weiss, S. R., Bröll, J., Minne, H. W., Quan, H., Bell, N. H., Rodriguez-Portales, J., Downs, R. W., Dequeker, J., Favus, M., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511303332201 · Cited by 2,288
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
Seeman, E., & Delmas, P. D. (2006) · New England Journal of Medicine · doi:10.1056/nejmra053077 · Cited by 2,080
Weinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2799 · Cited by 1,753
Self-citationKhosla, S., Burr, D., Cauley, J., Dempster, D. W., Ebeling, P. R., Felsenberg, D., Gagel, R. F., Gilsanz, V., Guise, T., Koka, S., et al. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0707onj · Cited by 1,650
Use of Inhaled Corticosteroids and Risk of Fractures
Van Staa, T. P., Leufkens, H. G. M., & Cooper, C. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.3.581 · Cited by 1,308
Glucocorticoid-induced osteoporosis: pathophysiology and therapy
Canalis, E., Mazziotti, G., Giustina, A., & Bilezikian, J. P. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0394-0 · Cited by 1,114
Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone
Jilka, R. L., Weinstein, R. S., Bellido, T., Roberson, P., Parfitt, A. M., & Manolagas, S. C. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6610 · Cited by 1,043
Self-citationAlendronate for the Treatment of Osteoporosis in Men
Orwoll, E., Ettinger, M., Weiss, S., Miller, P., Kendler, D., Graham, J., Adami, S., Weber, K., Lorenc, R., Pietschmann, P., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008313430902 · Cited by 973
Nontraumatic Necrosis of Bone (Osteonecrosis)
Desforges, J. F., & Mankin, H. J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205283262206 · Cited by 958
Teriparatide or Alendronate in Glucocorticoid-Induced Osteoporosis
Saag, K. G., Shane, E., Boonen, S., Marín, F., Donley, D. W., Taylor, K. A., Dalsky, G. P., & Marcus, R. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071408 · Cited by 914
Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin
Plotkin, L. I., Weinstein, R. S., Parfitt, A. M., Roberson, P. K., Manolagas, S. C., & Bellido, T. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6800 · Cited by 890
Self-citationO’Brien, C. A., Jia, D., Plotkin, L. I., Bellido, T., Powers, C. C., Stewart, S. A., Manolagas, S. C., & Weinstein, R. S. (2004) · Endocrinology · doi:10.1210/en.2003-0990 · Cited by 771
Self-citationGrossman, J. M., Gordon, R., Ranganath, V. K., Deal, C., Caplan, L., Chen, W., Curtis, J. R., Furst, D. E., McMahon, M., Patkar, N. M., et al. (2010) · Arthritis Care & Research · doi:10.1002/acr.20295 · Cited by 708
Reid, D. M., Hughes, R. A., Laan, R. F. J. M., Sacco-Gibson, N. A., Wenderoth, D. H., Adami, S., Eusebio, R. A., & Devogelaer, J.-P. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.6.1006 · Cited by 592
Van Staa, T. P., Laan, R. F., Barton, I. P., Cohen, S., Reid, D. M., & Cooper, C. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11283 · Cited by 559
Saag, K. G., Koehnke, R., Caldwell, J. R., Brasington, R., Burmeister, L. F., Zimmerman, B., Kohler, J. A., & Furst, D. E. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90131-7 · Cited by 540
Reid, D. M., Devogelaer, J.-P., Saag, K., Roux, C., Lau, C.-S., Reginster, J.-Y., Papanastasiou, P., Ferreira, A., Hartl, F., Fashola, T., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60250-6 · Cited by 527
Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur
Black, D. M., Kelly, M. P., Genant, H. K., Palermo, L., Eastell, R., Bucci-Rechtweg, C., Cauley, J., Leung, P. C., Boonen, S., Santora, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001086 · Cited by 512
Bernstein, C. N., Blanchard, J. F., Leslie, W., Wajda, A., & Yu, B. N. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-10-200011210-00012 · Cited by 474
Bisphosphonates in Bone Disease: From the Laboratory to the Patient
Fleisch, H. A. (1995) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 472
Glucocorticoids Act Directly on Osteoclasts to Increase Their Life Span and Reduce Bone Density
Jia, D., O’Brien, C. A., Stewart, S. A., Manolagas, S. C., & Weinstein, R. S. (2006) · Endocrinology · doi:10.1210/en.2006-0459 · Cited by 394
Self-citationGiant Osteoclast Formation and Long-Term Oral Bisphosphonate Therapy
Weinstein, R. S., Roberson, P. K., & Manolagas, S. C. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0802633 · Cited by 391
Self-citationBone loss in response to long-term glucocorticoid therapy
LoCascio, V., Bonucci, E., Imbimbo, B., Ballanti, P., Adami, S., Milani, S., Tartarotti, D., & DellaRocca, C. (1990) · Bone and Mineral · doi:10.1016/0169-6009(91)90139-q · Cited by 384
Apoptosis of Osteocytes in Glucocorticoid-Induced Osteonecrosis of the Hip1
Weinstein, R. S., Nicholas, R. W., & Manolagas, S. C. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6714 · Cited by 378
Self-citationAngeli, A., Guglielmi, G., Dovio, A., Capelli, G., de Feo, D., Giannini, S., Giorgino, R., Moro, L., & Giustina, A. (2006) · Bone · doi:10.1016/j.bone.2006.02.005 · Cited by 365
Lai, K.-A. (2005) · The Journal of Bone and Joint Surgery (American) · doi:10.2106/jbjs.d.02959 · Cited by 332
Perspectives bone histomorphometry in glucocorticoid-induced osteoporosis
Dr. Dempster, D. W. (1989) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650040202 · Cited by 319
Weinstein, R. S., Chen, J.-R., Powers, C. C., Stewart, S. A., Landes, R. D., Bellido, T., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214538 · Cited by 313
Self-citationApoptosis of Osteocytes in Glucocorticoid-Induced Osteonecrosis of the Hip
Weinstein, R. S. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.8.2907 · Cited by 313
Self-citationFracture risk with intermittent high‐dose oral glucocorticoid therapy
De Vries, F., Bracke, M., Leufkens, H. G. M., Lammers, J. J., Cooper, C., & Van Staa, T. P. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22294 · Cited by 298
Oral glucocorticoid use is associated with an increased risk of fracture
Steinbuch, M., Youket, T. E., & Cohen, S. (2004) · Osteoporosis International · doi:10.1007/s00198-003-1548-3 · Cited by 277
Weinstein, R. S., Wan, C., Liu, Q., Wang, Y., Almeida, M., O’Brien, C. A., Thostenson, J., Roberson, P. K., Boskey, A. L., Clemens, T. L., et al. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2009.00545.x · Cited by 276
Self-citationFelson, D., & Anderson, J. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92870-4 · Cited by 267
Dempster, D. W., Arlot, M. A., & Meunier, P. J. (1983) · Calcified Tissue International · doi:10.1007/bf02405069 · Cited by 233
Zelissen, P. M. J., Croughs, R. J. M., van Rijk, P. P., & Raymakers, J. A. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-3-199402010-00005 · Cited by 225
Jørgensen, N. R., Schwarz, P., Holme, I., Henriksen, B. M., Petersen, L. J., & Backer, V. (2007) · Respiratory Medicine · doi:10.1016/j.rmed.2006.03.029 · Cited by 221
Cooper, M. S., Rabbitt, E. H., Goddard, P. E., Bartlett, W. A., Hewison, M., & Stewart, P. M. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.6.979 · Cited by 200
Russcher, H., Smit, P., van den Akker, E. L. T., van Rossum, E. F. C., Brinkmann, A. O., de Jong, F. H., Lamberts, S. W. J., & Koper, J. W. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0646 · Cited by 199
Jahnsen, J., Falch, J. A., Mowinckel, P., & Aadland, E. (2002) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655202753416876 · Cited by 197
Bone loss in adults receiving alternate day glucocorticoid therapy
Gluck, O. S., Murphy, W. A., Hahn, T. J., & Hahn, B. (1981) · Arthritis & Rheumatism · doi:10.1002/art.1780240705 · Cited by 197
Dore, R. K., Cohen, S. B., Lane, N. E., Palmer, W., Shergy, W., Zhou, L., Wang, H., Tsuji, W., & Newmark, R. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.112920 · Cited by 194
Rubin, M. R., & Bilezikian, J. P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-012101 · Cited by 193
Glucocorticoid-Induced Osteoporosis
Weinstein, R. S. (2001) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1010007108155 · Cited by 189
Self-citationCorticosteroid-Induced Bone Loss in Men
Pearce, G. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.3.801 · Cited by 184
Apoptosis – a significant cause of bone cell death in osteonecrosis of the femoral head
Calder, J. D. F., Buttery, L., Revell, P. A., Pearse, M., & Polak, J. M. (2004) · The Journal of Bone and Joint Surgery. British volume · doi:10.1302/0301-620x.86b8.14834 · Cited by 178
Tauchmanovà, L., Pivonello, R., Somma, C. D., Rossi, R., Martino, M. C. D., Camera, L., Klain, M., Salvatore, M., Lombardi, G., & Colao, A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0582 · Cited by 159
Longitudinal patterns in the prevention of osteoporosis in glucocorticoid‐treated patients
Curtis, J. R., Westfall, A. O., Allison, J. J., Becker, A., Casebeer, L. L., Freeman, A. N., Spettell, C. M., Weissman, N., Wilke, S., & Saag, K. G. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21194 · Cited by 159
Devogelaer, J., Goemaere, S., Boonen, S., Body, J., Kaufman, J., Reginster, J., Rozenberg, S., & Boutsen, Y. (2005) · Osteoporosis International · doi:10.1007/s00198-005-2032-z · Cited by 155
Osteoporosis after Solid Organ Transplantation
Maalouf, N. M., & Shane, E. J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1978 · Cited by 154
Samaras, K., Pett, S. L., Gowers, A., McMurchie, M., & Cooper, D. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0036 · Cited by 139
Weinstein, R. S., Jilka, R. L., Almeida, M., Roberson, P. K., & Manolagas, S. C. (2010) · Endocrinology · doi:10.1210/en.2009-1488 · Cited by 116
Self-citationTeriparatide or Alendronate in Glucocorticoid-Induced Osteoporosis
Rossi, C. M., & Comite, G. D. (2008) · New England Journal of Medicine · doi:10.1056/nejmc073408 · Cited by 102
King, J. A., Wisniewski, A. B., Bankowski, B. J., Carson, K. A., Zacur, H. A., & Migeon, C. J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0745 · Cited by 101
Stockbrügger, R. W., Schoon, E. J., Bollani, S., Mills, P. R., Israeli, E., Landgraf, L., Felsenberg, D., Ljunghall, S., Nygård, G., Persson, T., et al. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01317.x · Cited by 99
The Skeletal Effects of Glucocorticoid Excess Override Those of Orchidectomy in Mice
Weinstein, R. S., Jia, D., Powers, C. C., Stewart, S. A., Jilka, R. L., PARFITT, A. M., & Manolagas, S. C. (2004) · Endocrinology · doi:10.1210/en.2003-1133 · Cited by 92
Self-citationIntact parathyroid hormone levels are not elevated in glucocorticoid-treated subjects
Paz-Pacheco, E. T., Fuleihan, G. E., & LeBoff, M. S. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650101114 · Cited by 79
Devogelaer, J., Adler, R. A., Recknor, C. P., See, K., Warner, M. R., Wong, M., & Krohn, K. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.090411 · Cited by 61
Safety of parathyroid hormone for the treatment of osteoporosis
Miller, P. D. (2008) · Current Osteoporosis Reports · doi:10.1007/s11914-008-0003-y · Cited by 60
Osteocyte viability with glucocorticoid treatment: relation to histomorphometry
Sambrook, P. N., Hughes, D. R., Nelson, A. E., Robinson, B. G., & Mason, R. S. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.008839 · Cited by 57
Hattersley, A. T., Meeran, K. M., Burrin, J. M., Hill, P. A., Shiner, R. J., & Ibbertson, H. K. (1994) · Calcified Tissue International · doi:10.1007/bf00301678 · Cited by 56
Tatsuno, I., Sugiyama, T., Suzuki, S., Yoshida, T., Tanaka, T., Sueishi, M., & Saitō, Y. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1578 · Cited by 54
Emkey, R. D., Delmas, P. D., Goemaere, S., Liberman, U. A., Poubelle, P. E., Daifotis, A. G., Verbruggen, N., Lombardi, A., & Czachur, M. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10861 · Cited by 47
The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment
Oxlund, H., Ørtoft, G., Thomsen, J. S., Danielsen, C. C., Ejersted, C., & Andreassen, T. T. (2006) · Bone · doi:10.1016/j.bone.2006.01.142 · Cited by 43
Symptomatic refractures after vertebroplasty in patients with steroid-induced osteoporosis.
Syed, M. I., Patel, N. A., Jan, S., Shaikh, A., Grunden, B. K., & Morar, K. (2006) · PubMed Central · Cited by 38
Fatal iatrogenic Cushing's syndrome
Nathan, A. W., & Rose, G. L. (1979) · The Lancet · doi:10.1016/s0140-6736(79)90597-x · Cited by 34
Vedi, S., Elkin, S., & Compston, J. E. (2005) · Calcified Tissue International · doi:10.1007/s00223-004-0205-y · Cited by 33
Glucocorticoid-Induced Osteoporosis
Adler, R. A., Curtis, J. R., Weinstein, R. S., & Saag, K. G. (2008) · Elsevier eBooks · doi:10.1016/b978-012370544-0.50046-x · Cited by 31
Self-citationThompson, J. M., Modin, G. W., Arnaud, C. D., & Lane, N. E. (1997) · Calcified Tissue International · doi:10.1007/s002239900351 · Cited by 27
Systemic Effects of Fluticasone Nasal Spray: Report of 2 Cases
Licata, A. A. (2005) · Endocrine Practice · doi:10.4158/ep.11.3.194 · Cited by 11
Warrington (2001) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200101)44:1 · Cited by 2
Cited by
Immune regulation by glucocorticoids
Cain, D. W., & Cidlowski, J. A. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.1 · Cited by 1,846
Complications of Cushing's syndrome: state of the art
Pivonello, R., Isidori, A. M., De Martino, M. C., Newell-Price, J., Biller, B. M. K., & Colao, A. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)00086-3 · Cited by 641
Nontraumatic Osteonecrosis of the Femoral Head: Where Do We Stand Today?: A Ten-Year Update
Mont, M. A., Cherian, J. J., Sierra, R. J., Jones, L. C., & Lieberman, J. R. (2015) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.o.00071 · Cited by 589
Physiological Bone Remodeling: Systemic Regulation and Growth Factor Involvement
Siddiqui, J. A., & Partridge, N. C. (2016) · Physiology · doi:10.1152/physiol.00061.2014 · Cited by 534
Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment
Chotiyarnwong, P., & McCloskey, E. V. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0341-0 · Cited by 489
Metadata
- Authors
- Weinstein, R. S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2011-07-07
- Volume
- 365
- Issue
- 1
- Pages
- 62-70
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2080089180
- Cited by
- 694
- References
- 71
- FWCI
- 48.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.